Article
Comparison of 13 Acellular Pertussis Vaccines: Overview and Serologic Response
Kathryn M. Edwards, Bruce D. Meade, Michael D. Decker, George F. Reed, Margaret B. Rennels, Mark C. Steinhoff, Edwin L. Anderson, Janet A. Englund, Michael E. Pichichero, Maria A. Deloria and Adamadia Deforest
Pediatrics September 1995, 96 (3) 548-557;
Kathryn M. Edwards
Bruce D. Meade
Michael D. Decker
George F. Reed
Margaret B. Rennels
Mark C. Steinhoff
Edwin L. Anderson
Janet A. Englund
Michael E. Pichichero
Maria A. Deloria

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Log in
You will be redirected to aap.org to login or to create your account.
Comparison of 13 Acellular Pertussis Vaccines: Overview and Serologic Response
Kathryn M. Edwards, Bruce D. Meade, Michael D. Decker, George F. Reed, Margaret B. Rennels, Mark C. Steinhoff, Edwin L. Anderson, Janet A. Englund, Michael E. Pichichero, Maria A. Deloria, Adamadia Deforest
Pediatrics Sep 1995, 96 (3) 548-557;
Comparison of 13 Acellular Pertussis Vaccines: Overview and Serologic Response
Kathryn M. Edwards, Bruce D. Meade, Michael D. Decker, George F. Reed, Margaret B. Rennels, Mark C. Steinhoff, Edwin L. Anderson, Janet A. Englund, Michael E. Pichichero, Maria A. Deloria, Adamadia Deforest
Pediatrics Sep 1995, 96 (3) 548-557;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Interference With Pertussis Vaccination in Infants After Maternal Pertussis Vaccination
- Bordetella Colonization Factor A (BcfA) Elicits Protective Immunity against Bordetella bronchiseptica in the Absence of an Additional Adjuvant
- Bordetella Colonization Factor A (BcfA) elicits protective immunity against Bordetella bronchiseptica in the absence of an additional adjuvant
- Challenges to Pertussis Control
- Assessment of humoral and cell-mediated immune responses to pertussis vaccination: a systematic review protocol
- What Is Wrong with Pertussis Vaccine Immunity?: Why Immunological Memory to Pertussis Is Failing
- What Is Wrong with Pertussis Vaccine Immunity?: The Problem of Waning Effectiveness of Pertussis Vaccines
- Reining in the "100-day cough": unfinished business
- Pertussis: Microbiology, Disease, Treatment, and Prevention
- Toward a new vaccine for pertussis
- Antibody Responses to Bordetella pertussis Fim2 or Fim3 following Immunization with a Whole-Cell, Two-Component, or Five-Component Acellular Pertussis Vaccine and following Pertussis Disease in Children in Sweden in 1997 and 2007
- Unraveling the challenges of pertussis
- Pertussis Booster Vaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy
- Analysis of Bordetella pertussis Populations in European Countries with Different Vaccination Policies
- Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies
- T-Cell Immune Response Assessment as a Complement to Serology and Intranasal Protection Assays in Determining the Protective Immunity Induced by Acellular Pertussis Vaccines in Mice
- Eighty-Kilodalton N-Terminal Moiety of Bordetella pertussis Filamentous Hemagglutinin: Adherence, Immunogenicity, and Protective Role
- Quantitative Priming with Inactivated Pertussis Toxoid Vaccine in the Aerosol Challenge Model
- Recombinant Mycobacterium bovis BCG Expressing Pertussis Toxin Subunit S1 Induces Protection against an Intracerebral Challenge with Live Bordetella pertussisin Mice
- Comparison of Five Commercial Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Bordetella pertussis
- Safety and Immunogenicity of Six Acellular Pertussis Vaccines and One Whole-Cell Pertussis Vaccine Given as a Fifth Dose in Four- to Six-Year-Old Children
- Cell-Mediated Immune Responses in Four-Year-Old Children after Primary Immunization with Acellular Pertussis Vaccines
- Protective Effects of Pertussis Immunoglobulin (P-IGIV) in the Aerosol Challenge Model
- An Evaluation of the Safety and Immunogenicity of a Five-Component Acellular Pertussis, Diphtheria, and Tetanus Toxoid Vaccine (DTaP) When Combined With a Haemophilus influenzaeType b-Tetanus Toxoid Conjugate Vaccine (PRP-T) in Taiwanese Infants
- Humoral Antibody Formation in Infants Aged One to Three Months Injected With a Triple (Diphtheria-Tetanus-Pertussis) Alum-precipitated Antigen, by William L. Bradford, MD, et al,Pediatrics, 1949;4:711-718
- A Murine Model in Which Protection Correlates with Pertussis Vaccine Efficacy in Children Reveals Complementary Roles for Humoral and Cell-Mediated Immunity in Protection againstBordetella pertussis
- A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT Vaccine